Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepastem in pediatric urea cycle disorders
KCT0003619Phase 2Withdrawn
- Sponsor
- HLB Cell
- Start
- Oct 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of hepastem in urea cycle disorder (UCD), sponsored by HLB Cell. Planned start Oct 2020; status: withdrawn.
02
Drugs
hepastem
03
Conditions
urea cycle disorder (UCD)
Beyond the preview
Go deeper on KCT0003619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003619.